{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:04:46Z","timestamp":1784081086809,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2022YFC2703902"],"award-info":[{"award-number":["2022YFC2703902"]}]},{"name":"Natural Science Foundation of Shanghai","award":["24ZR1410500"],"award-info":[{"award-number":["24ZR1410500"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To analyze maternal complications and pregnancy outcomes in pregnant women with severe cardiovascular disease (CVD), and explore the predictive value of pulmonary artery systolic pressure (PASP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) for these outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A retrospective observational study was conducted on pregnant women with severe CVD who were admitted to our hospital between December 2019 to August 2025. Demographic data, delivery mode, laboratory and imaging examination results, and post-partum follow-up data were collected. The primary outcome was CVD-related readmission or death during follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 158 patients (168 pregnancies) were included, with median follow-up of 1.8 (interquartile range 3.0) years. Among them, 86 cases achieved successful delivering, including 14 vaginal deliveries and 72 cesarean sections. Compared with the PASP\u2009&lt;\u200950 mmHg group, the PASP\u2009\u2265\u200950 mmHg group had a significantly higher medical abortion rate (34.5% vs. 12.2%), and a notably lower average birth weight (2247.5\u00a0g vs. 3042.5\u00a0g,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.007). ROC curve analysis revealed that the combined PASP\u2009+\u2009NT-proBNP index exhibited the highest predictive efficacy for the primary outcome (AUC\u2009=\u20090.748,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001), followed by NT-proBNP alone (AUC\u2009=\u20090.724,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003) and PASP alone (AUC\u2009=\u20090.664,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.028). Kaplan-Meier survival analysis demonstrated that pregnant women with elevated PASP (\u2265\u200944.5 mmHg; HR\u2009=\u20093.456, 95% CI: 1.367\u20138.734;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.009) or NT-proBNP (\u2265\u2009241.25 pg\/mL; HR\u2009=\u20096.863, 95% CI: 2.432\u201319.370;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) had a significantly increased risk of cardiovascular-related hospitalization or death during follow-up.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PASP may serve as a reference indicator for guiding perinatal risk assessment in pregnant women with severe CVD, while NT-proBNP could help optimize the long-term prognostic prediction of this population. The combined application of these two parameters might provide a preliminary basis for risk stratification, which may assist in clinical decision-making regarding perinatal management and long-term prognosis monitoring.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-026-09288-7","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T05:44:32Z","timestamp":1779428672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive efficacy of PASP combined with NT-proBNP for outcomes in pregnant women with severe cardiovascular disease: a single-centre retrospective observational study"],"prefix":"10.1186","volume":"26","author":[{"given":"Dan","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daxin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianzhou","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"9288_CR1","doi-asserted-by":"crossref","unstructured":"2018 ESC Guidelines for themanagement of cardiovascular diseases during pregnancy. Rev Esp Cardiol (Engl Ed). 2019;72(2):161.","DOI":"10.1016\/j.rec.2018.12.003"},{"issue":"47","key":"9288_CR2","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1093\/eurheartj\/ehz136","volume":"40","author":"J Roos-Hesselink","year":"2019","unstructured":"Roos-Hesselink J, Baris L, Johnson M, et al. Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry Of Pregnancy And Cardiac disease (ROPAC). Eur Heart J. 2019;40(47):3848\u201355.","journal-title":"Eur Heart J"},{"issue":"5","key":"9288_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1161\/hc3001.093437","volume":"104","author":"SC Siu","year":"2001","unstructured":"Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515\u201321.","journal-title":"Circulation"},{"key":"9288_CR4","unstructured":"De Backer J, Haugaa KH, Hasselberg NE et al. 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy. Eur Heart J. 2025 Nov 14; 46(43):4462-4568."},{"key":"9288_CR5","doi-asserted-by":"crossref","unstructured":"Nguyen HG, Nguyen KTH, Nguyen PN. Non-Pharmacological Management of Gestational Diabetes Mellitus with a High Fasting Glycemic Parameter: A Hospital-Based Study in Vietnam. J Clin Med. 2024;13(19):5895.","DOI":"10.3390\/jcm13195895"},{"issue":"9","key":"9288_CR6","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/ehs270","volume":"34","author":"JW Roos-Hesselink","year":"2013","unstructured":"Roos-Hesselink JW, Ruys TP, Stein JI, et al. Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. Eur Heart J. 2013;34(9):657\u201365.","journal-title":"Eur Heart J"},{"issue":"2","key":"9288_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jchf.2019.09.001","volume":"8","author":"K Sliwa","year":"2020","unstructured":"Sliwa K, Baris L, Sinning C, et al. Pregnant Women With Uncorrected Congenital Heart Disease: Heart Failure and Mortality. JACC Heart Fail. 2020;8(2):100\u201310.","journal-title":"JACC Heart Fail"},{"issue":"7","key":"9288_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/CIRCULATIONAHA.122.057987","volume":"147","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Zhu F, Shi G, et al. Maternal Outcomes Among Pregnant Women With Congenital Heart Disease-Associated Pulmonary Hypertension. Circulation. 2023;147(7):549\u201361.","journal-title":"Circulation"},{"issue":"10","key":"9288_CR9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1177\/2047487318821246","volume":"26","author":"Q Li","year":"2019","unstructured":"Li Q, Dimopoulos K, Liu T, et al. Peripartum outcomes in a large population of women with pulmonary arterial hypertension associated with congenital heart disease. Eur J Prev Cardiol. 2019;26(10):1067\u201376.","journal-title":"Eur J Prev Cardiol"},{"issue":"20","key":"9288_CR10","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/eurheartj\/ehae224","volume":"45","author":"A Sabbag","year":"2024","unstructured":"Sabbag A, Aabel EW, Castrini AI, et al. Mitral valve prolapse: arrhythmic risk during pregnancy and postpartum. Eur Heart J. 2024;45(20):1831\u20139.","journal-title":"Eur Heart J"},{"key":"9288_CR11","unstructured":"Nations TU. About the Sustainable Development Goals. [Z]. 2025.08.30. https:\/\/www.un.org\/sustainabledevelopment\/sustainable-development-goals\/."},{"issue":"2","key":"9288_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/ehjqcco\/qcac019","volume":"9","author":"C Bredy","year":"2023","unstructured":"Bredy C, Deville F, Huguet H, et al. Which risk score best predicts cardiovascular outcome in pregnant women with congenital heart disease?. Eur Heart J Qual Care Clin Outcomes. 2023;9(2):177\u201383.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"9288_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ijcard.2020.09.033","volume":"323","author":"N Denayer","year":"2021","unstructured":"Denayer N, Troost E, Santens B, et al. Comparison of risk stratification models for pregnancy in congenital heart disease. Int J Cardiol. 2021;323:54\u201360.","journal-title":"Int J Cardiol"},{"issue":"38","key":"9288_CR14","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert M, Kovacs G, Hoeper MM, et al. 2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43(38):3618\u2013731.","journal-title":"Eur Heart J"},{"issue":"7","key":"9288_CR15","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","volume":"23","author":"LG Rudski","year":"2010","unstructured":"Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685\u2013713. quiz 86\u2009\u2013\u20098.","journal-title":"J Am Soc Echocardiogr"},{"issue":"3","key":"9288_CR16","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.echo.2025.01.006","volume":"38","author":"M Mukherjee","year":"2025","unstructured":"Mukherjee M, Rudski LG, Addetia K, et al. Guidelines for the Echocardiographic Assessment of the Right Heart in Adults and Special Considerations in Pulmonary Hypertension: Recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2025;38(3):141\u201386.","journal-title":"J Am Soc Echocardiogr"},{"issue":"12","key":"9288_CR17","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.lpm.2019.08.007","volume":"48","author":"M Ladouceur","year":"2019","unstructured":"Ladouceur M. [Pregnancy and pulmonary arterial hypertension]. Presse Med. 2019;48(12):1422\u201330.","journal-title":"Presse Med"},{"issue":"16","key":"9288_CR18","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1136\/heartjnl-2015-308946","volume":"102","author":"MA Kampman","year":"2016","unstructured":"Kampman MA, Valente MA, Van Melle JP, et al. Cardiac adaption during pregnancy in women with congenital heart disease and healthy women. Heart. 2016;102(16):1302\u20138.","journal-title":"Heart"},{"issue":"2","key":"9288_CR19","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.ijcard.2012.10.005","volume":"168","author":"J Cornette","year":"2013","unstructured":"Cornette J, Ruys TP, Rossi A, et al. Hemodynamic adaptation to pregnancy in women with structural heart disease. Int J Cardiol. 2013;168(2):825\u201331.","journal-title":"Int J Cardiol"},{"key":"9288_CR20","doi-asserted-by":"crossref","unstructured":"Wald RM, Silversides CK, Kingdom J et al. Maternal Cardiac Output and Fetal Doppler Predict Adverse Neonatal Outcomes in Pregnant Women With Heart Disease. J Am Heart Assoc. 2015;4(11): 2414.","DOI":"10.1161\/JAHA.115.002414"},{"issue":"23","key":"9288_CR21","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1161\/CIRCULATIONAHA.113.002810","volume":"128","author":"PG Pieper","year":"2013","unstructured":"Pieper PG, Balci A, Aarnoudse JG, et al. Uteroplacental blood flow, cardiac function, and pregnancy outcome in women with congenital heart disease. Circulation. 2013;128(23):2478\u201387.","journal-title":"Circulation"},{"issue":"11","key":"9288_CR22","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.4103\/jfmpc.jfmpc_1877_21","volume":"11","author":"N Sharma","year":"2022","unstructured":"Sharma N, Khan DA, Das R, et al. Maternal mortality and predictors of adverse outcome in patients with heart disease in pregnancy. J Family Med Prim Care. 2022;11(11):6752\u20138.","journal-title":"J Family Med Prim Care"},{"issue":"8","key":"9288_CR23","doi-asserted-by":"publisher","first-page":"e009018","DOI":"10.1161\/CIRCHEARTFAILURE.121.009018","volume":"15","author":"SA Chang","year":"2022","unstructured":"Chang SA, Khakh P, Janzen M, et al. Trending Cardiac Biomarkers During Pregnancy in Women With Cardiovascular Disease. Circ Heart Fail. 2022;15(8):e009018.","journal-title":"Circ Heart Fail"},{"issue":"12","key":"9288_CR24","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1093\/ehjci\/jeae173","volume":"25","author":"AC Egbe","year":"2024","unstructured":"Egbe AC, Miranda WR, Jain CC, et al. Cardiac remodelling during pregnancy in women with congenital heart disease and systemic left ventricle. Eur Heart J Cardiovasc Imaging. 2024;25(12):1695\u2013702.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"9288_CR25","doi-asserted-by":"publisher","first-page":"814557","DOI":"10.3389\/fcvm.2022.814557","volume":"9","author":"LL Dai","year":"2022","unstructured":"Dai LL, Jiang TC, Li PF, et al. Predictors of Maternal Death Among Women With Pulmonary Hypertension in China From 2012 to 2020: A Retrospective Single-Center Study. Front Cardiovasc Med. 2022;9:814557.","journal-title":"Front Cardiovasc Med"},{"issue":"32","key":"9288_CR26","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1093\/eurheartj\/eht070","volume":"34","author":"CJ Coats","year":"2013","unstructured":"Coats CJ, Gallagher MJ, Foley M, et al. Relation between serum N-terminal pro-brain natriuretic peptide and prognosis in patients with hypertrophic cardiomyopathy. Eur Heart J. 2013;34(32):2529\u201337.","journal-title":"Eur Heart J"},{"issue":"19","key":"9288_CR27","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1093\/eurheartj\/ehaa768","volume":"42","author":"A Reid","year":"2021","unstructured":"Reid A, Blanke P, Bax JJ, et al. Multimodality imaging in valvular heart disease: how to use state-of-the-art technology in daily practice. Eur Heart J. 2021;42(19):1912\u201325.","journal-title":"Eur Heart J"},{"key":"9288_CR28","doi-asserted-by":"crossref","unstructured":"Zhang X, Zhai Z, Geng X et al. Doppler Echocardiography Combined with NTproBNP\/BNP in the Diagnosis of Pulmonary Artery Hypertension Associated with Congenital Heart Disease. Comput Math Methods Med. 2023;2023:1896026.","DOI":"10.1155\/2023\/1896026"},{"issue":"6","key":"9288_CR29","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.21037\/cdt-24-248","volume":"14","author":"D Csengeri","year":"2024","unstructured":"Csengeri D, Unger E, Weimann J, et al. Pregnancy & cardiovascular disease: the PREG-CVD-HH registry. Cardiovasc Diagn Ther. 2024;14(6):1058\u201369.","journal-title":"Cardiovasc Diagn Ther"},{"issue":"1","key":"9288_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12937-021-00726-0","volume":"20","author":"BF Sunguya","year":"2021","unstructured":"Sunguya BF, Ge Y, Mlunde L, et al. High burden of anemia among pregnant women in Tanzania: a call to address its determinants. Nutr J. 2021;20(1):65.","journal-title":"Nutr J"},{"issue":"1","key":"9288_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5152\/cjm.2025.25019","volume":"49","author":"U Erkok","year":"2025","unstructured":"Erkok U, Top\u00e7u G, Yildiz P, G\u00fcner G, Hassan IS, G\u00f6k K, Barut A. The Impact of Maternal Anaemia on Foetal Growth Parameters in Somali Women: A Cross-Sectional Study. Cerrahpa\u015fa Med J. 2025;49(1):1\u20136.","journal-title":"Cerrahpa\u015fa Med J"},{"key":"9288_CR32","doi-asserted-by":"crossref","unstructured":"Feleke BE, Feleke TE. The Effect of Pregnancy in the Hemoglobin Concentration of Pregnant Women: A Longitudinal Study. J Pregnancy. 2020;2020:2789536.","DOI":"10.1155\/2020\/2789536"},{"issue":"3","key":"9288_CR33","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1165\/rcmb.2017-0308OC","volume":"59","author":"O Rafikova","year":"2018","unstructured":"Rafikova O, Williams ER, Mcbride ML, et al. Hemolysis-induced Lung Vascular Leakage Contributes to the Development of Pulmonary Hypertension. Am J Respir Cell Mol Biol. 2018;59(3):334\u201345.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"Suppl 2","key":"9288_CR34","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12978-020-01006-6","volume":"17","author":"SA Ali","year":"2020","unstructured":"Ali SA, Tikmani SS, Saleem S, et al. Hemoglobin concentrations and adverse birth outcomes in South Asian pregnant women: findings from a prospective Maternal and Neonatal Health Registry. Reprod Health. 2020;17(Suppl 2):154.","journal-title":"Reprod Health"},{"issue":"1","key":"9288_CR35","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12884-023-05489-6","volume":"23","author":"MF Young","year":"2023","unstructured":"Young MF, Oaks BM, Rogers HP, et al. Maternal low and high hemoglobin concentrations and associations with adverse maternal and infant health outcomes: an updated global systematic review and meta-analysis. BMC Pregnancy Childbirth. 2023;23(1):264.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"21","key":"9288_CR36","doi-asserted-by":"publisher","first-page":"e009395","DOI":"10.1161\/JAHA.118.009395","volume":"7","author":"A Owens","year":"2018","unstructured":"Owens A, Yang J, Nie L, et al. Neonatal and Maternal Outcomes in Pregnant Women With Cardiac Disease. J Am Heart Assoc. 2018;7(21):e009395.","journal-title":"J Am Heart Assoc"},{"key":"9288_CR37","doi-asserted-by":"crossref","unstructured":"Guner G, Karabudak CB. Caesarean section rates and indications: a cross-sectional study from a tertiary care centre in Turkiye. BMC Pregnancy Childbirth. 2025 Nov 24; 26(1):1.","DOI":"10.1186\/s12884-025-08494-z"},{"issue":"7","key":"9288_CR38","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1161\/HYPERTENSIONAHA.124.24472","volume":"82","author":"JJ Edwards","year":"2025","unstructured":"Edwards JJ, Giorgione V, Griffiths M, et al. Cardiac Structure, Function and Mechanics in Hypertensive Disorders of Pregnancy: A Systematic Review and Meta-Analysis. Hypertension. 2025;82(7):e129\u201339.","journal-title":"Hypertension"},{"key":"9288_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejogrb.2023.11.007","volume":"292","author":"A Sonaglioni","year":"2024","unstructured":"Sonaglioni A, Bordoni T, Naselli A, et al. Influence of gestational diabetes mellitus on subclinical myocardial dysfunction during pregnancy: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2024;292:17\u201324.","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-09288-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09288-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09288-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:34:18Z","timestamp":1784079258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-026-09288-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9288"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-09288-7","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Ethics Committee of Zhongshan Hospital, Fudan University (approval number: B2022-593R), and all participants provided written informed consent in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"772"}}